Title of article :
Radiolabeled theranostics: magnetic and gold nanoparticles
Author/Authors :
Omidi Yadollah Research Center for Pharmaceutical Nanotechnology - Tabriz University of Medical Sciences - Tabriz, Iran , Barar Jaleh Research Center for Pharmaceutical Nanotechnology - Tabriz University of Medical Sciences - Tabriz, Iran , Same Saeideh Research Center for Pharmaceutical Nanotechnology - Tabriz University of Medical Sciences - Tabriz, Iran , Aghanejad Ayuob Research Center for Pharmaceutical Nanotechnology - Tabriz University of Medical Sciences - Tabriz, Iran , Akbari Nakhjavani Sattar Research Center for Pharmaceutical Nanotechnology - Tabriz University of Medical Sciences - Tabriz, Iran
Abstract :
Growing advances in nanotechnology
have facilitated the applications of newly emerged
nanomaterials in the field of biomedical/
pharmaceutical sciences. Following this trend, the
multifunctional nanoparticles (NPs) play a significant
role in development of advanced drug delivery systems
(DDSs) such as diapeutics/theranostics used for
simultaneous diagnosis and therapy. Multifunctional
radiolabeled NPs with capability of detecting,
visualizing and destroying diseased cells with least
side effects have been considered as an emerging
filed in presentation of the best choice in solving
the therapeutic problems. Functionalized magnetic
and gold NPs (MNPs and GNPs, respectively) have
produced the potential of nanoparticles as sensitive multifunctional probes for molecular
imaging, photothermal therapy and drug delivery and targeting.
Methods: In this study, we review the most recent works on the improvement of various techniques
for development of radiolabeled magnetic and gold nanoprobes, and discuss the methods for
targeted imaging and therapies.
Results: The receptor-specific radiopharmaceuticals have been developed to localized
radiotherapy in disease sites. Application of advanced multimodal imaging methods and related
modality imaging agents labeled with various radioisotopes (e.g., 125I, 111In, 64Cu, 68Ga, 99mTc) and
MNPs/GNPs have significant effects on treatment and prognosis of cancer therapy. In addition,
the surface modification with biocompatible polymer such as polyethylene glycol (PEG) have
resulted in development of stealth NPs that can evade the opsonization and immune clearance.
These long-circulating agents can be decorated with homing agents as well as radioisotopes for
targeted imaging and therapy purposes.
Conclusion: The modified MNPs or GNPs have wide applications in concurrent diagnosis and
therapy of various malignancies. Once armed with radioisotopes, these nanosystems (NSs) can
be exploited for combined multimodality imaging with photothermal/photodynamic therapy
while delivering the loaded drugs or genes to the targeted cells/tissues. These NSs will be a game
changer in combating various cancers.
Keywords :
Nuclear imaging , PET/SPECT , Radiolabeled nanoparticles , Theranostics
Journal title :
Bioimpacts